Trading Signals: ILMN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Illumina Inc)
| ILMN latest price $352.3200 (0.84%) ($345.0900 - $353.4700) on Tue. Sep. 11, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 75 | Latest Price | $352.3200(0.84%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ILMN advances 1.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ILMN advance at 0% a week (0% probability) IBB(65%) IWF(58%) IWO(58%) QQQ(58%) IVW(57%) | Factors Impacting ILMN price | ILMN will decline at least -1.02% in a week (0% probabilities). VXX(-15%) VIXM(-12%) UUP(-12%) SHY(-5%) XHB(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | 0 () | Intraday Trend | 1% | | | |
|
5 Day Moving Average | $348.27(1.16%) | 10 Day Moving Average | $349.75(0.73%) | 20 Day Moving Average | $341.71(3.1%) | To recent high | -0.7% | To recent low | 30.2% | Market Cap | $51.439b | | | | Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA. |